Johns Hopkins logo

Health Newsfeed

CONSIDERING STATINS

WHEN IS IT WORTH CONSIDERING A STATIN? ELIZABETH TRACEY REPORTS

A series known as 'Less is More' in Archives of Internal Medicine offers the opinion that there is very little evidence that many people who are prescribed statins to reduce cholesterol and lower risk of heart attacks actually benefit. Roger Blumenthal, director of the Cicarrone Center for Preventive Cardiology at Johns Hopkins, begs to differ.

BLUMENTHAL: National guidelines that we have now indicate that if you have a 20% risk of a heart attack in the next 10 years, then we should try to get the LDL cholesterol, the bad cholesterol, down below 100, and we have many large studies that show that high risk individuals above a certain age with other risk factors should go ahead and have their cholesterol levels lowered, so to say that there's no evidence that lipid lowering therapy should be used in asymptomatic patients even if they have high Framingham risk scores, is really irresponsible. :29

Blumenthal says heart disease remains the number one cause of death, so everyone should carefully consider his or her own risk factors and possible interventions, including statin medications. At Johns Hopkins, I'm Elizabeth Tracey.

 



Search Health NewsFeed

-----------------------------------------
Health NewsFeed Home | Hopkins Medicine Home